Every reference with a DOI in the deposited reference list resolved to a known
work in Crossref or DataCite at the dated check, and none carried a retraction,
withdrawal, or removal notice.
The 58 checked references that resolve
resolves10.1111/imr.12233Targeting the bone marrow microenvironment in multiple myeloma
resolves10.1182/blood-2009-05-220285Macrophages are an abundant component of myeloma microenvironment and protect myeloma cells from chemotherapy drug–induced apoptosis
resolves10.1182/blood-2012-08-448548Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans
resolves10.1016/j.ccell.2018.02.007Dysregulated IL-18 Is a Key Driver of Immunosuppression and a Possible Therapeutic Target in the Multiple Myeloma Microenvironment
resolves10.1038/leu.2015.191Tumor-associated macrophages and extracellular matrix metalloproteinase inducer in prognosis of multiple myeloma
resolves10.1038/leu.2012.141Anti-CD47 antibodies promote phagocytosis and inhibit the growth of human myeloma cells
resolves10.1080/19420862.2015.1007813Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myeloma
resolves10.1038/s41375-018-0114-0Lenalidomide enhances MOR202-dependent macrophage-mediated effector functions via the vitamin D pathway
resolves10.1016/S2352-3026(15)00197-0Elotuzumab in combination with lenalidomide and dexamethasone in patients with relapsed multiple myeloma: final phase 2 results from the randomised, open-label, phase 1b–2 dose-escalation study
resolves10.4049/jimmunol.177.10.7303Transcriptional Profiling of the Human Monocyte-to-Macrophage Differentiation and Polarization: New Molecules and Patterns of Gene Expression
resolves10.1038/ni.1990IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses
resolves10.7150/jca.30102High numbers of CD163+ tumor-associated macrophages correlate with poor prognosis in multiple myeloma patients receiving bortezomib-based regimens
resolves10.1038/bjc.2016.11High level of interleukin-10 in serum predicts poor prognosis in multiple myeloma
resolves10.1126/science.1244851Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells
resolves10.1073/pnas.0400983101Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria
resolves10.12703/P6-13The M1 and M2 paradigm of macrophage activation: time for reassessment
resolves10.1182/blood-2003-06-1984BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone
resolves10.1038/nature22076SLAMF7 is critical for phagocytosis of haematopoietic tumour cells via Mac-1 integrin
resolves10.4049/jimmunol.1502198CD44 Antibody Inhibition of Macrophage Phagocytosis Targets Fcγ Receptor– and Complement Receptor 3–Dependent Mechanisms
resolves10.1182/blood-2011-08-372425Human CD300a binds to phosphatidylethanolamine and phosphatidylserine, and modulates the phagocytosis of dead cells
resolves10.4049/jimmunol.0713732M2 Macrophages Phagocytose Rituximab-Opsonized Leukemic Targets More Efficiently than M1 Cells In Vitro
resolves10.1038/leu.2016.214The PD-1/PD-L1 axis contributes to immune metabolic dysfunctions of monocytes in chronic lymphocytic leukemia
resolves10.1111/j.1365-2141.2011.08689.xLenalidomide downregulates the cell survival factor, interferon regulatory factor‐4, providing a potential mechanistic link for predicting response
resolves10.1038/ni.1920The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection
resolves10.1182/blood-2015-02-628669CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL
resolves10.1016/j.celrep.2016.04.001TNF-Mediated Restriction of Arginase 1 Expression in Myeloid Cells Triggers Type 2 NO Synthase Activity at the Site of Infection
resolves10.1182/blood-2006-07-037754Interleukin 2 gene transcription is regulated by Ikaros-induced changes in histone acetylation in anergic T cells
resolves10.1038/leu.2015.331Epigenetic regulation of gene expression by Ikaros, HDAC1 and Casein Kinase II in leukemia
resolves10.1038/nature14610Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS
resolves10.1158/2326-6066.CIR-15-0025-TTumoricidal Effects of Macrophage-Activating Immunotherapy in a Murine Model of Relapsed/Refractory Multiple Myeloma
resolves10.1200/JCO.2014.59.9258Randomized Trial of Lenalidomide Alone Versus Lenalidomide Plus Rituximab in Patients With Recurrent Follicular Lymphoma: CALGB 50401 (Alliance)
resolves10.1038/nri3088Transcriptional regulation of macrophage polarization: enabling diversity with identity
resolves10.1101/gad.297002.117The making of a lymphocyte: the choice among disparate cell fates and the IKAROS enigma
resolves10.1016/j.immuni.2009.01.014Genome-wide Lineage-Specific Transcriptional Networks Underscore Ikaros-Dependent Lymphoid Priming in Hematopoietic Stem Cells
resolves10.4049/jimmunol.1800158Dual Roles for Ikaros in Regulation of Macrophage Chromatin State and Inflammatory Gene Expression
resolves10.1111/imr.12209Mi‐2/Nu<scp>RD</scp> chromatin remodeling complexes regulate B and T‐lymphocyte development and function
resolves10.1007/s00296-010-1576-1Down-regulated expression of IKZF1 mRNA in peripheral blood mononuclear cells from patients with systemic lupus erythematosus
resolves10.1038/ng.472Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus
resolves10.1080/2162402X.2015.1016699Ikaros deficiency in host hematopoietic cells separates GVL from GVHD after experimental allogeneic hematopoietic cell transplantation
resolves10.1038/s41409-019-0449-9G-CSF-induced macrophage polarization and mobilization may prevent acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
checked 2026-07-23 — re-checked daily as this page is visited;
titles and statuses come from Crossref and DataCite and are not part of the signed record
Both snippets point at the live badge image and link back to this page. The
badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.